Rigrodsky & Long, P.A.
announces that a complaint has been filed in the United States District Court for the Western District of Louisiana on behalf of all persons or entities that purchased the common stock of LHC Group, Inc. (“LHC” or the “Company”) (NASDAQ GS:
) between July 30, 2008 and October 26, 2011, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).
If you purchased shares of LHC Group during the Class Period, or purchased shares prior to the Class Period and still hold LHC Group, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact
Timothy J. MacFall, Esquire
or Peter Allocco of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, NY at (888) 969-4242, by e-mail to
, or at:
LHC, a Delaware corporation headquartered in Lafayette, Louisiana, is a health care provider specializing in the post-acute continuum of care primarily for Medicare beneficiaries. The Company provides home-based services, primarily through home nursing agencies and hospices, and facility-based services, primarily through long-term acute care hospitals. The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. Specifically, the Complaint alleges that the Defendants failed to disclose that the reported growth in LHC’s home-based healthcare segment during the Class Period was created, in large part, by the Company engaging in a pattern of practice designed to achieve the most profitable number of therapy visits, regardless of patient need, to maximize revenue. As a result of defendants’ false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.